Drug Information
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cyclin A2 (CCNA2) | Target Info | Inhibitor | [2] |
| Cyclin-dependent kinase 2 (CDK2) | Target Info | Inhibitor | [2] | |
| Cyclin-dependent kinase 4 (CDK4) | Target Info | Inhibitor | [3] | |
| Cyclin-dependent kinase 6 (CDK6) | Target Info | Inhibitor | [3] | |
| FGFR4 messenger RNA (FGFR4 mRNA) | Target Info | Inhibitor | [2] | |
| Fibroblast growth factor receptor 1 (FGFR1) | Target Info | Inhibitor | [2] | |
| Fibroblast growth factor receptor 2 (FGFR2) | Target Info | Inhibitor | [2] | |
| Fibroblast growth factor receptor 3 (FGFR3) | Target Info | Inhibitor | [2] | |
| G1/S-specific cyclin-E1 (CCNE1) | Target Info | Inhibitor | [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014130) | |||
| REF 2 | Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases. J Med Chem. 2000 Nov 30;43(24):4606-16. | |||
| REF 3 | Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci. 2002 Sep;23(9):417-25. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.